Dr. Yong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5 E 98th St
New York, NY 10029Phone+1 212-241-5493Fax+1 212-831-3324- Is this information wrong?
Summary
- I am an academic neurosurgeon with a clinical and research interest in malignant brain tumors. I completed medical school and residency training in Canada, as well as research training at MD Anderson Cancer Center, and fellowship training at the Surgical Neurology Branch, NIH Clinical Center. My laboratory focuses on characterizing genomic evolutionary dynamics in diffuse gliomas.
Education & Training
Clinical Center at the National Institutes of HealthFellowship, Neurosurgical Oncology, 2010 - 2013
University of British ColumbiaFRCSC, Residency in Neurosurgery, 2002 - 2010
University of Texas M. D. Anderson Cancer CenterMS, Cancer Biology, 2006 - 2008
University of Calgary Faculty of MedicineClass of 2002, MD
Certifications & Licensure
NY State Medical License 2013 - 2026- Royal College of Physicians and Surgeons of CanadaNeurosurgery
Awards, Honors, & Recognition
- American Brain Tumor Association Young Investigator Award AANS/CNS Section on Tumors
- Preuss Award for Basic Neurosurgical Research AANS/CNS Section on Tumors
Publications & Presentations
PubMed
- CDKN2A mutations have equivalent prognostic significance to homozygous deletion in IDH-mutant astrocytoma.Raquel T Yokoda, William S Cobb, Raymund L Yong, John F Crary, Mariano S Viapiano, Jamie M Walker, Melissa Umphlett, Nadejda M Tsankova, Timothy E Richardson> ;Journal of Neuropathology and Experimental Neurology. 2023 Sep 20
- 2 citationsThe prognostic impact of subclonal IDH1 mutation in grade 2-4 astrocytomas.Meenakshi Vij, Raquel T Yokoda, Omid Rashidipour, Ivy Tran, Varshini Vasudevaraja, Matija Snuderl, Raymund L Yong, William S Cobb, Melissa Umphlett, Jamie M Walker, Na...> ;Neuro-Oncology Advances. 2023 May 29
- 5 citationsA Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma.Daniel Chiu, Jingjing Qi, Tin Htwe Thin, Monica Garcia-Barros, Brian Lee, Mary Hahn, John Mandeli, Puneet Belani, Kambiz Nael, Omid Rashidipour, Saadi Ghatan, Constant...> ;Cancer Research Communications. 2023 Jan 1
- Join now to see all
Journal Articles
- Review Comparison of Glioblastoma (GBM) Molecular Classification MethodsRaymund Yong, MD, ScienceDirect
Press Mentions
Mount Sinai, Sema4 Data Scientists Tout Brain Cancer BreakthroughOctober 16th, 2017
Mount Sinai & Sema4 Scientists Identify Biomarker for Progression and Drug Response in Brain CancerOctober 16th, 2017
Professional Memberships
- Member
Hospital Affiliations
The Mount Sinai HospitalNew York, New York
Mount Sinai MorningsideNew York, New York
Mount Sinai Beth IsraelNew York, New York
NYC Health + Hospitals / ElmhurstElmhurst, New York
Mount Sinai WestNew York, New York
NYC Health + Hospitals / South Brooklyn HealthBrooklyn, New York
Mount Sinai Hospital of QueensAstoria, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
